Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Impaired protein hydroxylase activity causes replication stress and developmental abnormalities in humans
Sally C. Fletcher, … , Katrin Õunap, Mathew L. Coleman
Sally C. Fletcher, … , Katrin Õunap, Mathew L. Coleman
Published February 16, 2023
Citation Information: J Clin Invest. 2023;133(7):e152784. https://doi.org/10.1172/JCI152784.
View: Text | PDF
Research Article Cell biology Genetics

Impaired protein hydroxylase activity causes replication stress and developmental abnormalities in humans

  • Text
  • PDF
Abstract

Although protein hydroxylation is a relatively poorly characterized posttranslational modification, it has received significant recent attention following seminal work uncovering its role in oxygen sensing and hypoxia biology. Although the fundamental importance of protein hydroxylases in biology is becoming clear, the biochemical targets and cellular functions often remain enigmatic. JMJD5 is a “JmjC-only” protein hydroxylase that is essential for murine embryonic development and viability. However, no germline variants in JmjC-only hydroxylases, including JMJD5, have yet been described that are associated with any human pathology. Here we demonstrate that biallelic germline JMJD5 pathogenic variants are deleterious to JMJD5 mRNA splicing, protein stability, and hydroxylase activity, resulting in a human developmental disorder characterized by severe failure to thrive, intellectual disability, and facial dysmorphism. We show that the underlying cellular phenotype is associated with increased DNA replication stress and that this is critically dependent on the protein hydroxylase activity of JMJD5. This work contributes to our growing understanding of the role and importance of protein hydroxylases in human development and disease.

Authors

Sally C. Fletcher, Charlotte Hall, Tristan J. Kennedy, Sander Pajusalu, Monica H. Wojcik, Uncaar Boora, Chan Li, Kaisa Teele Oja, Eline Hendrix, Christian A.E. Westrip, Regina Andrijes, Sonia K. Piasecka, Mansi Singh, Mohammed E. El-Asrag, Anetta Ptasinska, Vallo Tillmann, Martin R. Higgs, Deanna A. Carere, Andrew D. Beggs, John Pappas, Rachel Rabin, Stephen J. Smerdon, Grant S. Stewart, Katrin Õunap, Mathew L. Coleman

×

Figure 2

Patient variants affect JMJD5 mRNA splicing and enzyme structure.

Options: View larger image (or click on image) Download as PowerPoint
Patient variants affect JMJD5 mRNA splicing and enzyme structure.
(A) Ca...
(A) Carriers of the intronic variant express an altered JMJD5 mRNA (lower band). JMJD5 cDNA from exon 3 to the 3′-UTR was amplified from the indicated samples and separated by gel electrophoresis. The coding sequence of the wild-type (WT) JMJD5 mRNA (ENST00000286096.8, NM_024773) spanning this region is 706 bp (upper band). CY, C123Y; In, intronic mutant. (B) Graphical representation of the incorrectly spliced intronic variant mRNA (top) and protein (bottom) demonstrating the loss of sequence integral to the catalytic domain (compare with the correctly spliced mRNA in D). Fe(II)- and 2OG-binding residues are marked by red and blue arrowheads, respectively. (C) Structure of the catalytic domain of JMJD5 (Protein Data Bank: 4GAZ) with critical catalytic residues labeled. The region encoded by exon 7 that is missing from JMJD5Δ332–362 is highlighted in green. (D) Graphical representation of the C123Y JMJD5 mRNA and protein. The position of the C123Y missense variant within exon 2 and the JMJD5 N-terminus is highlighted (top). Structural predictions suggest that the JMJD5 N-terminus is predominantly α-helical (bottom left; also see Supplemental Figure 12). C123 is highly conserved (bottom right) and predicted to be located within a hydrophobic environment on one side of an amphipathic α-helix within a TPR domain (bottom middle; also see Supplemental Figure 12).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts